Connect with us
[bsa_pro_ad_space id=12]

International

‘They’re So Dishonest’: Doctor Unloads On Media For Asking Biden ‘Terrible’ Questions Instead Of ‘Grilling’ Him

Published

5 minute read

From the Daily Caller News Foundation

By JASON COHEN

 

Physician and medical professor Dr. Vinay Prasad criticized the media on Thursday for not asking President Joe Biden the right questions to assess his cognitive capability.

Democrats have increasingly been encouraging Biden to drop out of the presidential race after his debate performance against former President Donald Trump, which caused worries regarding the president’s mental competence. Prasad on his YouTube channel said the media should challenge the president’s capability through asking tougher questions rather than pushing him to take a cognitive test.

WATCH: 

“The media, they’re so so relentlessly focused on whether or not he should get a neurologic test. I think they fundamentally misunderstand. Yes, if you’re his doctor, you might want to do tests on this gentleman, but if you’re vetting a candidate for this office, the test is learn how to ask better questions,” Prasad said. “The questions they ask are so terrible. Ask pointed questions, ask really questions that force him to retrieve memories, ask questions that really ask him to articulate.”

“Don’t ask open-ended questions that allow him to filibuster and just go back to saying the stock and trade things he says all the time that come out like rote memorization,” he continued. “Push him in different domains. You can actually assess someone for president if you are a competent journalist and ask the right questions. They don’t appear to do that.”

Corporate media’s years-long effort to quash questions regarding Biden’s mental fitness faced a substantial setback after the debate. Despite worries from Americans, legacy media outlets consistently downplayed their legitimacy.

“We have to admit that they’re completely dishonest. Before the debate, when 50 million Americans watched him with word-finding difficulties and things of that nature … they were running a media campaign that said any video you saw of him was probably doctored or it was taken out of context because, of course, the man is doing just fine,” Prasad said. “They never raised the question of, ‘is he performing, this 80-plus-year-old gentleman is up for the task of being president?’ They never raised that question. The moment that everyone saw it, and then the jig was up and they couldn’t conceal these deficits anymore … now they’re suddenly happy to run op-ed after op-ed and calls for him to step down.”

“They’re so dishonest, this media. What are you doing in the White House Press Corps? Don’t you see the man? Aren’t you assessing him daily? Why are you keeping that a goddamn secret?” he asked.

Biden recently sat down for an interview with ABC News’ George Stephanopoulos in an effort to reassure voters that he is capable of being president, asserting his debate performance was just a “bad night” and that he is not cognitively diminished. The president also seemed to express an unwillingness to take a cognitive test.

“No amount of medical testing is going to answer the question of if somebody is fit enough to be president of the United States. Just like no amount of imaging and test questionnaires is going to tell you if a college kid is able to play in the NBA,” Prasad added. “You have to watch them play basketball and you have to watch him engage in the sorts of acts that one would expect from a president.”

“It would probably involve, I would imagine, being woken up in the middle of the night and having to get your opinion on a bunch of big issues and that might happen like many nights in a row, so you might have some chronic sleep deprivation,” he said. “How would you perform under those circumstances? You might get a sense for that if you were really grilling somebody in a vigorous dialogue and vigorous questioning, which the media didn’t want to do for all this time.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Artificial Intelligence

AI Faces Energy Problem With Only One Solution, Oil and Gas

Published on

 

From the Daily Caller News Foundation

By David Blackmon

Which came first, the chicken or the egg? It’s one of the grand conundrums of history, and it is one that is impacting the rapidly expanding AI datacenter industry related to feeding its voracious electricity needs.

Which comes first, the datacenters or the electricity required to make them go? Without the power, nothing works. It must exist first, or the datacenter won’t go. Without the datacenter, the AI tech doesn’t go, either.

Logic would dictate that datacenter developers who plan to source their power needs with proprietary generation would build it first, before the datacenter is completed. But logic is never simple when billions in capital investment is at risk, along with the need to generate profits as quickly as possible.

Dear Readers:

As a nonprofit, we are dependent on the generosity of our readers.

Please consider making a small donation of any amount here.

Thank you!

Building a power plant is a multi-year project, which itself involves heavy capital investment, and few developers have years to wait. The competition with China to win the race to become the global standard setters in the AI realm is happening now, not in 2027, when a new natural gas plant might be ready to go, or in 2035, the soonest you can reasonably hope to have a new nuclear plant in operation.

Some developers still virtue signal about wind and solar, but the industry’s 99.999% uptime requirement renders them impractical for this role. Besides, with the IRA subsidies on their way out, the economics no longer work.

So, if the datacenter is the chicken in this analogy and the electricity is the egg, real-world considerations dictate that, in most cases, the chicken must come first. That currently leaves many datacenter developers little choice but to force their big demand loads onto the local grid, often straining available capacity and causing utility rates to rise for all customers in the process.

This reality created a ready-made political issue that was exploited by Democrats in the recent Virginia and New Jersey elections, as they laid all the blame on their party’s favorite bogeyman, President Donald Trump. Never mind that this dynamic began long before Jan. 20, when Joe Biden’s autopen was still in charge: This isn’t about the pesky details, but about politics.

In New Jersey, Democrat winner Mikie Sherrill exploited the demonization tactic, telling voters she plans to declare a state of emergency on utility costs and freeze consumers’ utility rates upon being sworn into office. What happens after that wasn’t specified, but it made a good siren song to voters struggling to pay their utility bills each month while still making ends meet.

In her Virginia campaign, Democrat gubernatorial winner Abigail Spanberger attracted votes with a promise to force datacenter developers to “pay their own way and their fair share” of the rising costs of electricity in her state. How she would make that happen is anyone’s guess and really didn’t matter: It was the tactic that counted, and big tech makes for almost as good a bogeyman as Trump or oil companies.

For the Big Tech developers, this is one of the reputational prices they must pay for putting the chicken before the egg. On the positive side, though, this reality is creating big opportunity in other states like Texas. There, big oil companies Chevron and ExxonMobil are both in talks with hyperscalers to help meet their electricity needs.

Chevron has plans to build a massive power generation facility that would exploit its own Permian Basin natural gas production to provide as much as 2.5 gigawatts of power to regional datacenters. CEO Mike Wirth says his team expects to make a final investment decision early next year with a target to have the first plant up and running by the end of 2027.

ExxonMobil CEO Darren Woods recently detailed his company’s plans to leverage its expertise in the realm of carbon capture and storage to help developers lower their emissions profiles when sourcing their needs via natural gas generation.

“We secured locations. We’ve got the existing infrastructure, certainly have the know-how in terms of the technology of capturing, transporting and storing [carbon dioxide],” Woods told investors.

It’s an opportunity-rich environment in which companies must strive to find ways to put the eggs before the chickens before ambitious politicians insert themselves into the process. As the recent elections showed, the time remaining to get that done is growing short.

David Blackmon is an energy writer and consultant based in Texas. He spent 40 years in the oil and gas business, where he specialized in public policy and communications.

Continue Reading

Dr John Campbell

Cures for Cancer? A new study shows incredible results from cheap generic drug Fenbendazole

Published on

From Dr. John Campbell

FenBen in Stage 4 cancer

You won’t hear much about Fenbendazole from the regular pipeline of medical information.  There could be many reasons for that. For one, it’s primarily known for it’s use in veterinary medicine.  Somehow during COVID the medical information pipeline convinced millions that if a drug is used on horses or other animals it couldn’t work for humans.  Not sure how they got away with that one considering the use of animal trials for much of modern medical history.

Another possible reason, one that makes at least as much sense, is that there’s no business case for Fenbendazole.  It’s been around for decades and its patent expired in the early 1990’s.  That means it’s considered a generic drug that a pharmaceutical company from India could (and does) produce in mass quantities for very little profit (compared to non-generics).

So Fenbendazole is an inexpensive, widely accessible antiparasitic drug used in veterinary medicine.  During the COVID pandemic a number of doctors, desperate for a suitable treatment, tried it with reportedly great levels of success.  Over some time they discovered it might be useful elsewhere.  Some doctors are using Fenbendazole to help treat late stage cancer.  Often this is prescribed when the regular treatments clearly aren’t working and cancer is approaching or has already been declared stage 4.

What they’ve found at least in some cases is astounding results.  This has resulted in a new study which medical researcher Dr. John Campbell shares in this video.

Continue Reading

Trending

X